Pure Global

XGEVA 120 MG SC SOLUTION FOR INJECTION, 4 PCS - Turkey License ae48c7d3bb7063202f2b96792ff66e5a

Access comprehensive regulatory information for XGEVA 120 MG SC SOLUTION FOR INJECTION, 4 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number ae48c7d3bb7063202f2b96792ff66e5a with license number 2022/469and contains active ingredient Denosumab . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
ae48c7d3bb7063202f2b96792ff66e5a
License Details
Turkey SFDA License: ae48c7d3bb7063202f2b96792ff66e5a
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

XGEVA 120 MG SC SOLUTION FOR INJECTION, 4 PCS
TR: XGEVA 120 MG SC ENJEKSİYONLUK ÇÖZELTİ, 4 ADET
Pharmaceutical Product

License Details

ae48c7d3bb7063202f2b96792ff66e5a

2022/469

8699862770132

M05BX04

License Holder Information

Active Ingredient

Denosumab

License Information

Aug 23, 2022